miRNA expression patterns in chemoresistant breast cancer tissues

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chemoresistance in breast cancer poses a significant challenge to effective patient treatment.
• MicroRNAs (miRNAs) play crucial roles in tumorigenesis and chemoresistance, yet clinical data on their expression patterns in breast cancer chemoresistance is limited.

Purpose of the Study:

• To investigate the differential expression patterns of specific miRNAs in doxorubicin-resistant breast cancer cells and chemoresistant patient tissues.
• To identify potential miRNA biomarkers for predicting breast cancer chemoresistance and therapeutic outcomes.

Main Methods:

• Established a doxorubicin-resistant MCF-7 cell line (MCF-7/Adr) and verified its resistance.
• Utilized quantitative real-time PCR (qRT-PCR) to analyze the expression of 14 selected miRNAs.
• Performed bioinformatics analyses (Gene Ontology and KEGG) to predict the functions of miRNA-targeted genes.
• Assessed miRNA expression levels in clinical samples from chemotherapy responders and non-responders.

Main Results:

• The MCF-7/Adr cell line exhibited significant resistance to doxorubicin compared to parental MCF-7 cells.
• 14 miRNAs showed differential expression in MCF-7/Adr cells, with 6 over-expressed and 7 down-regulated.
• Bioinformatics analysis linked these miRNAs to key cellular processes including signaling pathways (e.g., MAPK) and gene regulation.
• Ten miRNAs were found to be dysregulated in chemoresistant breast cancer tissues, with 3 up-regulated and 7 down-regulated.

Conclusions:

• Identified 10 dysregulated miRNAs in both breast cancer cells and chemoresistant tissues that may serve as prognostic biomarkers.
• These miRNA signatures could inform the development of novel targeted therapeutic strategies for chemoresistant breast cancer.